Valiant Laboratories Limited

NSE VALIANTLAB.NS

Valiant Laboratories Limited Market Capitalization on January 31, 2025: USD 50.14 M

Valiant Laboratories Limited Market Capitalization is USD 50.14 M on January 31, 2025, a -50.90% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Valiant Laboratories Limited 52-week high Market Capitalization is USD 102.10 M on February 02, 2024, which is 103.65% above the current Market Capitalization.
  • Valiant Laboratories Limited 52-week low Market Capitalization is USD 47.46 M on January 28, 2025, which is -5.34% below the current Market Capitalization.
  • Valiant Laboratories Limited average Market Capitalization for the last 52 weeks is USD 67.56 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
SV Wall Street
NSE: VALIANTLAB.NS

Valiant Laboratories Limited

CEO Mr. Santosh Shantilal Vora
IPO Date Oct. 6, 2023
Location India
Headquarters 104, Udyog Kshetra
Employees 77
Sector Industrials
Industries
Petrochemicals Chemicals & Advanced Materials Cleaning Supplies Drugstores & Retail Pharmacies Non-Alcoholic Beverages Personal Care Pharmaceuticals Plastics
Description

Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and is based in Mumbai, India. Valiant Laboratories Limited is a subsidiary of Dhanvallabh Ventures LLP.

StockViz Staff

February 2, 2025

Any question? Send us an email